Loading...
0

Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Opportunity Analysis and Industry Forecast, 2018 - 2025

LI_161677
Pages: 225
Mar 2019 | 5824 Views
 
Author(s) : Sohail Shaikh & Onkar Sumant
Tables: 93
Charts: 65
 

Proteomics Market Outlook-2025

The global proteomics market was valued at $24,361million in 2017, and is expected to reach $72,444 million by 2025, growing at a CAGR of 14.5% during the forecast period.

Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time. Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Structural proteomics is used to identify the structure of protein complexes, while functional proteomics is used for characterizing the protein‐protein interactions to demonstrate protein functions.

Proteomics finds extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis, which have escalated the growth of the proteomics market in the past few years. With increase in awareness regarding the benefits of personalized medicines, companies and government organizations have increased their R&D expenditure on the development of proteomics.

Get more information on this report : Request Sample Pages

The global proteomics market is expected to grow at a significant rate throughout the forecast period, owing to increase in popularity of personalized medicines, upsurge in R&D expenditure and technological advancements associated with proteomics. Furthermore, rise in awareness and availability of proteomics instruments in both developed and emerging market boosts the market growth. However, high costs associated with proteomics components and dearth of skilled professionals in the proteomics industry impede the growth of the market. On the contrary, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are anticipated to provide lucrative growth opportunities to the market players.

The global proteomics market is segmented based on component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is subsegmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. The chromatography segment is subclassified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report : Request Sample Pages

The global proteomics market size is analyzed through the component vertical in the report. By component, the proteomics market for reagents occupied the largest share in 2017; this trend is expected to continue throughout the forecast period, as reagents are an integral part of proteomics components. Reagents are used as binding materials and precursors of chemical reactions during analysis of the protein structure and characterization. Moreover, basic proteomics protocols require reagents, therefore, this segment is anticipated to occupy the largest market share in the component segment throughout the forecast period.

Get more information on this report : Request Sample Pages

The global proteomics market share is analyzed through the application vertical in the report. By application, the drug discovery segment occupied the largest share in 2017. The growth in the biopharmaceutical market has created lucrative opportunities for development of precision medicine, which is anticipated to cumulatively supplement the market growth for drug discovery using proteomics.

Get more information on this report : Request Sample Pages

Furthermore, the global proteomics market trends are analyzed through the region vertical. By region, North America is anticipated to occupy the largest share in 2025, owing to heavy funding by various organizations and increase in adoption of agreements & collaborations. Moreover, rise in R&D investments is anticipated to facilitate the market growth during the forecast period.

Increase in competition and continuous technological advancements have led to enhancements in the product portfolio; hence, product development is one of the key developmental strategies adopted by the market players in the global proteomics market.

For instance, in June 2018, Bruker Corporation introduced a broad line of mass spectrometry products and workflows at the ASMS (American Society for Mass Spectrometry) conference. Likewise, in March 2017, ThermoFisher Scientific, Inc. launched iXR Raman Spectrometer. This new product was designed for rapid and accurate chemical and structural analysis. Furthermore, in January 2019, Waters Corporation introduced the BioAccord System, a liquid chromatography-mass spectrometry (LC-MS) solution that is anticipated to expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists Considerable increase has been witnessed in acquisitions and collaborations in the global proteomics industry. For instance, in June 2018, Waters Corporation acquired the exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and the Purdue Research Foundation (PRF). Similarly, in February 2017, Thermo Fisher Scientific, Inc. acquired Finesse Solutions, based in California, a leader in development of scalable control automation systems and software for bioproduction. This business was expected to integrate in Thermo Fisher’s Life Sciences Solutions Segment to optimize bioproduction workflow. Moreover, in June 2018, Thermo Scientific and Evosep collaborated to develop and promote robust, high-throughput workflows for clinical proteomics at the 66th Conference on Mass Spectrometry and Allied Topics.

The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.

Key Benefits for Proteomics Market:

  • The report provides an extensive analysis of the global proteomics market size, current market trends and future estimations of the market.
  • The global proteomics market analysis is comprehensively covered with respect to the component, application, and region.
  • The global proteomics market growth estimations in this report are based on high-end analysis of the key developments for 2018‐2025.
  • Recent developments, key manufacturers, and top player positioning are listed in this report to analyze the competitive scenario of the market.

Proteomics Key Market Segments:

By Component

  • Instruments
    • Microarray
    • Spectrometry
      • Mass Spectrometry
      • NMR Spectrometry
    • X-ray Crystallography
    • Chromatography
      • HPLC Systems
      • Ion Chromatography
      • Affinity Chromatography
      • Supercritical Fluid Chromatography
    • Electrophoresis
    • Surface Plasmon Resonance
    • Protein Fractionation Reagents
  • Reagents
    • Microarray
    • Spectroscopy
    • X-ray Crystallography
    • Chromatography
    • Electrophoresis
    • Immunoassay
    • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments

1.3.1.    List of key players profiled in the report

1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study

2.1.1.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top winning strategies
3.2.2.    Top investment pockets
3.2.3.    Top player positioning

3.3.    Porter’s five forces analysis
3.4.    Market dynamics

3.4.1.    Drivers

3.4.1.1.    Increase in popularity of personalized medicines
3.4.1.2.    Upsurge in R&D expenditure
3.4.1.3.    Technological advancements associated with proteomics components

3.4.2.    Restraints

3.4.2.1.    High costs associated with proteomics components
3.4.2.2.    Dearth of skilled professionals

3.4.3.    Opportunities

3.4.3.1.    Lucrative opportunities associated with biomarker identification
3.4.3.2.    Developments in mass spectrometry-based proteomics

CHAPTER 4:    PROTEOMICS MARKET, BY COMPONENT

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Reagents

4.2.1.    Key market trends, growth factors, and opportunities
4.2.2.    Market size and forecast
4.2.3.    Microarray

4.2.3.1.    Market size and forecast

4.2.4.    Spectrometry

4.2.4.1.    Market size and forecast

4.2.5.    X-ray crystallography

4.2.5.1.    Market size and forecast

4.2.6.    Chromatography

4.2.6.1.    Market size and forecast

4.2.7.    Electrophoresis

4.2.7.1.    Market size and forecast

4.2.8.    Immunoassay

4.2.8.1.    Market size and forecast

4.2.9.    Protein fractionation reagents

4.2.9.1.    Market size and forecast

4.2.10.    Market analysis, by country

4.3.    Instruments

4.3.1.    Key market trends, growth factors, and opportunities
4.3.2.    Market size and forecast
4.3.3.    Microarray

4.3.3.1.    Market size and forecast

4.3.4.    Spectrometry

4.3.4.1.    Market size and forecast

4.3.4.1.1.    Mass spectrometry

4.3.4.1.1.1.    Market size and forecast

4.3.4.1.2.    NMR spectrometry

4.3.4.1.2.1.    Market size and forecast

4.3.5.    Chromatography

4.3.5.1.    Market size and forecast

4.3.5.1.1.    HPLC systems

4.3.5.1.1.1.    Market size and forecast

4.3.5.1.2.    Ion chromatography

4.3.5.1.2.1.    Market size and forecast

4.3.5.1.3.    Affinity chromatography

4.3.5.1.3.1.    Market size and forecast

4.3.5.1.4.    Supercritical fluid chromatography

4.3.5.1.4.1.    Market size and forecast

4.3.6.    Electrophoresis

4.3.6.1.    Market size and forecast

4.3.7.    Surface plasmon resonance

4.3.7.1.    Market size and forecast

4.3.8.    X-ray crystallography

4.3.8.1.    Market size and forecast

4.3.9.    Protein fractionation systems

4.3.9.1.    Market size and forecast

4.3.10.    Market analysis, by country

4.4.    Services

4.4.1.    Key market trends, growth factors, and opportunities
4.4.2.    Market size and forecast
4.4.3.    Market analysis, by country

CHAPTER 5:    PROTEOMICS MARKET, BY APPLICATION

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Drug discovery

5.2.1.    Market size and forecast
5.2.2.    Market analysis, by country

5.3.    Disease diagnosis

5.3.1.    Market size and forecast
5.3.2.    Market analysis, by country

5.4.    Others

5.4.1.    Market size and forecast
5.4.2.    Market analysis, by country

CHAPTER 6:    PROTEOMICS MARKET, BY REGION

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    North America

6.2.1.    Key market trends, growth factors, and opportunities
6.2.2.    Market size and forecast, by country

6.2.2.1.    U.S.

6.2.2.1.1.    U.S. proteomics market, by component
6.2.2.1.2.    U.S. proteomics market, by application

6.2.2.2.    Canada

6.2.2.2.1.    Canada proteomics market, by component
6.2.2.2.2.    Canada proteomics market, by application

6.2.2.3.    Mexico

6.2.2.3.1.    Mexico proteomics market, by component
6.2.2.3.2.    Mexico proteomics market, by application

6.2.3.    North America proteomics market, by component
6.2.4.    North America proteomics market, by application

6.3.    Europe

6.3.1.    Key market trends, growth factors, and opportunities
6.3.2.    Market size and forecast, by country

6.3.2.1.    Germany

6.3.2.1.1.    Germany proteomics market, by component
6.3.2.1.2.    Germany proteomics market, by application

6.3.2.2.    France

6.3.2.2.1.    France proteomics market, by component
6.3.2.2.2.    France proteomics market, by application

6.3.2.3.    UK

6.3.2.3.1.    UK proteomics market, by component
6.3.2.3.2.    UK proteomics market, by application

6.3.2.4.    Italy

6.3.2.4.1.    Italy proteomics market, by component
6.3.2.4.2.    ITALY proteomics market, by application

6.3.2.5.    Spain

6.3.2.5.1.    Spain proteomics market, by component
6.3.2.5.2.    Spain proteomics market, by application

6.3.2.6.    Rest of Europe

6.3.2.6.1.    Rest of Europe proteomics market, by component
6.3.2.6.2.    Rest of Europe proteomics market, by application

6.3.3.    Europe proteomics market, by component
6.3.4.    Europe proteomics market, by application

6.4.    Asia-Pacific

6.4.1.    Key market trends, growth factors, and opportunities

6.4.1.1.    Japan

6.4.1.1.1.    Japan proteomics market, by component
6.4.1.1.2.    Japan proteomics market, by application

6.4.1.2.    China

6.4.1.2.1.    China proteomics market, by component
6.4.1.2.2.    China proteomics market, by application

6.4.1.3.    India

6.4.1.3.1.    India proteomics market, by component
6.4.1.3.2.    India proteomics market, by application

6.4.1.4.    Australia

6.4.1.4.1.    Australia proteomics market, by component
6.4.1.4.2.    Australia proteomics market, by application

6.4.1.5.    South Korea

6.4.1.5.1.    South Korea proteomics market, by component
6.4.1.5.2.    South Korea proteomics market, by application

6.4.1.6.    Rest of Asia-Pacific

6.4.1.6.1.    Rest of Asia-Pacific proteomics market, by component
6.4.1.6.2.    Rest of Asia-Pacific proteomics market, by application

6.4.2.    Asia-Pacific proteomics market, by component
6.4.3.    Asia-Pacific proteomics market, by application

6.5.    LAMEA

6.5.1.    Key market trends, growth factors, and opportunities
6.5.2.    Market size and forecast, by country

6.5.2.1.    Brazil

6.5.2.1.1.    Brazil proteomics market, by component
6.5.2.1.2.    Brazil proteomics market, by application

6.5.2.2.    Saudi Arabia

6.5.2.2.1.    Saudi Arabia proteomics market, by component
6.5.2.2.2.    Saudi Arabia proteomics market, by application

6.5.2.3.    South Africa

6.5.2.3.1.    South Africa proteomics market, by component
6.5.2.3.2.    South Africa proteomics market, by application

6.5.2.4.    Rest of LAMEA

6.5.2.4.1.    Rest of LAMEA proteomics market, by component
6.5.2.4.2.    Rest of LAMEA proteomics market, by application

6.5.3.    LAMEA proteomics market, by component
6.5.4.    LAMEA proteomics market, by application

CHAPTER 7:    COMPANY PROFILES

7.1.    AGILENT TECHNOLOGIES, INC.

7.1.1.    Company overview
7.1.2.    Company snapshot
7.1.3.    Operating business segments
7.1.4.    Product portfolio
7.1.5.    Business performance
7.1.6.    Key strategic moves and developments

7.2.    DANAHER CORPORATION (BECKMAN COULTER, INC.)

7.2.1.    Company overview
7.2.2.    Company snapshot
7.2.3.    Operating business segments
7.2.4.    Product portfolio
7.2.5.    Business performance

7.3.    LI-COR, INC.

7.3.1.    Company overview
7.3.2.    Company snapshot
7.3.3.    Operating business segments
7.3.4.    Product portfolio

7.4.    PERKINELMER INC.

7.4.1.    Company overview
7.4.2.    Company snapshot
7.4.3.    Operating business segments
7.4.4.    Product Portfolio
7.4.5.    Business performance
7.4.6.    Key strategic moves and developments

7.5.    THERMO FISHER SCIENTIFIC, INC.

7.5.1.    Company overview
7.5.2.    Company snapshot
7.5.3.    Operating business segments
7.5.4.    Product portfolio
7.5.5.    Business performance
7.5.6.    Key strategic moves and developments

7.6.    HORIBA, LTD.

7.6.1.    Company overview
7.6.2.    Company snapshot
7.6.3.    Operating business segments
7.6.4.    Product portfolio
7.6.5.    Business performance

7.7.    BIO-RAD LABORATORIES, INC.

7.7.1.    Company overview
7.7.2.    Company snapshot
7.7.3.    Operating business segments
7.7.4.    Product type Portfolio
7.7.5.    Business performance
7.7.6.    Key strategic moves and developments

7.8.    BRUKER CORPORATION (BECKMAN COULTER, INC.)

7.8.1.    Company overview
7.8.2.    Company snapshot
7.8.3.    Operating business segments
7.8.4.    Product type portfolio
7.8.5.    Business performance
7.8.6.    Key strategic moves and developments

7.9.    GE HEALTHCARE (GENERAL ELECTRIC)

7.9.1.    Company overview
7.9.2.    Company snapshot
7.9.3.    Operating business segments
7.9.4.    Product Portfolio
7.9.5.    Business performance

7.10.    WATERS CORPORATION (BECKMAN COULTER, INC.)

7.10.1.    Company overview
7.10.2.    Company snapshot
7.10.3.    Operating business segments
7.10.4.    Product type portfolio
7.10.5.    Business performance
7.10.6.    Key strategic moves and developments

LIST OF TABLES

TABLE 01.    GLOBAL PROTEOMICS REAGENTS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 02.    PROTEOMICS REAGENTS MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 03.    PROTEOMICS REAGENTS MARKET, BY COMPONENT TYPE, 2017–2025 ($MILLION)
TABLE 04.    PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 05.    PROTEOMICS INSTRUMENTS MARKET, BY COMPONENT TYPE, 2017–2025 ($MILLION)
TABLE 06.    PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, BY TYPE, 2017–2025 ($MILLION)
TABLE 07.    PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2017–2025 ($MILLION)
TABLE 08.    PROTEOMICS SERVICES MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 09.    GLOBAL PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 10.    PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2017–2025 ($MILLION)
TABLE 11.    PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2017–2025 ($MILLION)
TABLE 12.    PROTEOMICS MARKET FOR OTHERS, BY REGION, 2017–2025 ($MILLION)
TABLE 13.    PROTEOMICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 14.    NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 15.    U.S. PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 16.    U.S. PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 17.    CANADA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 18.    CANADA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 19.    MEXICO PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 20.    MEXICO PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 21.    NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 22.    NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 23.    EUROPE PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 24.    GERMANY PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 25.    GERMANY PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 26.    FRANCE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 27.    FRANCE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 28.    UK PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 29.    UK PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 30.    ITALY PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 31.    ITALY PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 32.    SPAIN PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 33.    SPAIN PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 34.    REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 35.    REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 36.    EUROPE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 37.    EUROPE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 38.    ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 39.    JAPAN PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 40.    JAPAN PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 41.    CHINA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 42.    CHINA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 43.    INDIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 44.    INDIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 45.    AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 46.    AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 47.    SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 48.    SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 49.    REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 50.    REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 51.    ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 52.    ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 53.    LAMEA PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 54.    BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 55.    BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 56.    SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 57.    SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 58.    SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 59.    SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 60.    REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 61.    REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 62.    LAMEA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)
TABLE 63.    LAMEA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 64.    AGILENT: COMPANY SNAPSHOT
TABLE 65.    AGILENT: OPERATING SEGMENTS
TABLE 66.    AGILENT : PRODUCT PORTFOLIO
TABLE 67.    DANAHER: COMPANY SNAPSHOT
TABLE 68.    DANAHER: OPERATING SEGMENTS
TABLE 69.    DANAHER: PRODUCT PORTFOLIO
TABLE 70.    LI-COR, INC.: COMPANY SNAPSHOT
TABLE 71.    LI-COR, INC.: OPERATING SEGMENTS
TABLE 72.    LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 73.    PERKINELMER: COMPANY SNAPSHOT
TABLE 74.    PERKINELMER: OPERATING SEGMENTS
TABLE 75.    PERKINELMER: PRODUCT PORTFOLIO
TABLE 76.    THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 77.    THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 78.    THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79.    HORIBA: COMPANY SNAPSHOT
TABLE 80.    HORIBA: BUSINESS SEGMENTS
TABLE 81.    HORIBA: PRODUCT PORTFOLIO
TABLE 82.    BIO-RAD: COMPANY SNAPSHOT
TABLE 83.    BIO-RAD: OPERATING SEGMENTS
TABLE 84.    BIO-RAD: PRODUCT TYPE PORTFOLIO
TABLE 85.    BRUKER: COMPANY SNAPSHOT
TABLE 86.    BRUKER: OPERATING SEGMENTS
TABLE 87.    BRUKER: PRODUCT TYPE PORTFOLIO
TABLE 88.    GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 89.    GE HEALTHCARE: OPERATING SEGMENTS
TABLE 90.    GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 91.    WATERS: COMPANY SNAPSHOT
TABLE 92.    WATERS: OPERATING SEGMENTS
TABLE 93.    WATERS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    GLOBAL PROTEOMICS MARKET SEGMENTATION
FIGURE 02.    TOP WINNING STRATEGIES, 2016–2019
FIGURE 03.    TOP WINNING STRATEGIES, PERCENTAGE & DISTRIBUTION, 2016–2019
FIGURE 04.    DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05.    TOP INVESTMENT POCKETS
FIGURE 06.    TOP PLAYER POSITIONING, 2017
FIGURE 07.    HIGH BARGAINING POWER OF BUYERS
FIGURE 08.    LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09.    MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.    MODERATE THREAT OF SUBSTITUTION
FIGURE 11.    MODERATE COMPETITIVE RIVALRY
FIGURE 12.    DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.    PROTEOMICS REAGENTS MARKET FOR MICROARRAY, 2017–2025 ($MILLION)
FIGURE 14.    PROTEOMICS REAGENTS MARKET FOR SPECTROMETRY, 2017–2025 ($MILLION)
FIGURE 15.    PROTEOMICS REAGENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2017–2025 ($MILLION)
FIGURE 16.    PROTEOMICS REAGENTS MARKET FOR CHROMATOGRAPHY, 2017–2025 ($MILLION)
FIGURE 17.    PROTEOMICS REAGENTS MARKET FOR ELECTROPHORESIS, 2017–2025 ($MILLION)
FIGURE 18.    PROTEOMICS REAGENTS MARKET FOR IMMUNOASSAY, 2017–2025 ($MILLION)
FIGURE 19.    PROTEOMICS REAGENTS MARKET FOR PROTEIN FRACTIONATION REAGENTS, 2017–2025 ($MILLION)
FIGURE 20.    COMPARATIVE SHARE ANALYSIS OF PROTEOMICS REAGENTS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21.    PROTEOMICS INSTRUMENTS MARKET FOR MICROARRAY, 2017–2025 ($MILLION)
FIGURE 22.    PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, 2017–2025 ($MILLION)
FIGURE 23.    PROTEOMICS INSTRUMENTS MARKET FOR MASS SPECTROMETRY, 2017–2025 ($MILLION)
FIGURE 24.    NMR SPECTROMETRY PROTEOMICS INSTRUMENTS MARKET, 2017–2025 ($MILLION)
FIGURE 25.    PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, 2017–2025 ($MILLION)
FIGURE 26.    PROTEOMICS INSTRUMENTS MARKET FOR HPLC SYSTEMS, 2017–2025 ($MILLION)
FIGURE 27.    PROTEOMICS INSTRUMENTS MARKET FOR ION CHROMATOGRAPHY, 2017–2025 ($MILLION)
FIGURE 28.    PROTEOMICS INSTRUMENTS MARKET FOR AFFINITY CHROMATOGRAPHY, 2017–2025 ($MILLION)
FIGURE 29.    PROTEOMICS INSTRUMENTS MARKET FOR SUPERFICIAL FLUID CHROMATOGRAPHY, 2017–2025 ($MILLION)
FIGURE 30.    PROTEOMICS INSTRUMENTS MARKET FOR ELECTROPHORESIS, 2017–2025 ($MILLION)
FIGURE 31.    PROTEOMICS INSTRUMENTS MARKET FOR SURFACE PLASMON RESONANCE, 2017–2025 ($MILLION)
FIGURE 32.    PROTEOMICS INSTRUMENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2017–2025 ($MILLION)
FIGURE 33.    PROTEOMICS INSTRUMENTS MARKET FOR PROTEIN FRACTIONATION SYSTEMS, 2017–2025 ($MILLION)
FIGURE 34.    COMPARATIVE SHARE ANALYSIS OF PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 35.    COMPARATIVE SHARE ANALYSIS OF PROTEOMICS SERVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 36.    COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DRUG DISCOVERY, BY COUNTRY,  2017 & 2025 (%)
FIGURE 37.    COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY,  2017 & 2025 (%)
FIGURE 38.    COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR OTHER, BY COUNTRY, 2017 & 2025 (%)
FIGURE 39.    AGILENT: REVENUE, 2015–2017 ($MILLION)
FIGURE 40.    AGILENT: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 41.    AGILENT: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 42.    DANAHER: NET SALES, 2015–2017 ($MILLION)
FIGURE 43.    DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 44.    DANAHER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 45.    PERKINELMER: NET SALES, 2015–2017 ($MILLION)
FIGURE 46.    PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 47.    PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 48.    THERMO FISHER SCIENTIFIC: REVENUE, 2015–2017 ($MILLION)
FIGURE 49.    THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 50.    THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 51.    HORIBA: NET SALES, 2015–2017 ($MILLION)
FIGURE 52.    HORIBA: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 53.    HORIBA: NET SALES, BY REGION, 2017 (%)
FIGURE 54.    BIO-RAD: NET SALES, 2015–2017 ($MILLION)
FIGURE 55.    BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 56.    BIO-RAD: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 57.    BRUKER: NET SALES, 2015–2017 ($MILLION)
FIGURE 58.    BRUKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59.    BRUKER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60.    GE HEALTHCARE: NET SALES, 2015–2017 ($MILLION)
FIGURE 61.    GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 62.    GE HEALTHCARE: REVENUE SHARE BY REGION, 2017(%)
FIGURE 63.    WATERS: NET SALES, 2015–2017 ($MILLION)
FIGURE 64.    WATERS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 65.    WATERS: REVENUE SHARE BY REGION, 2017 (%)

 
 

The global proteomics market is expected to witness significant growth in the future. The market has piqued the interest of the healthcare industry, as proteomics helps to bridge the gap between the understanding of genome expression and cellular behavior as well as aids in increasing the popularity of personalized medicines.

The need for personalized medicines is anticipated to increase considerably, which will fuel the growth of the global market. Furthermore, the use of proteomics is the highest in the North American region, followed by Europe and Asia-Pacific, owing to heavy R&D expenditure and increased research funding from various organizations, such as National Institutes of Health (NIH).

North America is expected to remain dominant during the forecast. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to increase in disposable income of populace, improvement in healthcare infrastructure, and rise in demand for advanced technologies, such as proteomics.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Proteomics Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Proteomics Market"
Purchase Enquiry